Evolution of the Average Target: Tempus AI, Inc.

Evolution of the Average Target - Tempus AI, Inc.

Evolution of the Target Price: Tempus AI, Inc.

Evolution of the Target Price - Tempus AI, Inc.

Changes in Analyst Recommendations: Tempus AI, Inc.

c661c1543679fbd5eca9142f9b219514.HwaVqwD_xitjH5bW_SLKw3bLrJYF3bSOBdxi24zDoe0.JkPD31a6rE43UfCusGerjVv82e48vNDbNZomnu6266lNK9PRVq-jXDAt_Q~64e71b1daa3fc68bce0d669f5b0d39d3
21/09 Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target MT
09/09 UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target MT
08/09 Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target MT
02/09 Cantor Fitzgerald Initiates Tempus AI at Overweight With $80 Price Target MT
01/09 Piper Sandler Upgrades Tempus AI to Overweight From Neutral, Adjusts PT to $76 From $56 MT
01/09 Analyst recommendations: Duolingo, Robinhood, Adobe, CrowdStrike, Salesforce… Zonebourse
21/07 Personalis Acquisition Price Warranted by Growth Prospects, Needham Says MT
21/07 Tempus AI to Buy Cancer Test Maker Personalis; Needham Says Deal Premium Well Above Peers MT
20/07 Top Midday Decliners MT
13/04 TD Cowen Upgrades Tempus AI to Buy From Hold, Adjusts Price Target to $65 From $70 MT
13/04 Jefferies Initiates Tempus AI at Underperform With $35 Price Target MT
25/02 Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead… Zonebourse
19/02 Mizuho Securities Initiates Coverage on Tempus AI With Outperform Rating, $100 Price Target MT
17/02 Baird Initiates Tempus AI at Outperform With $59 Price Target MT
02/12 Morgan Stanley Raises Price Target on Tempus AI to $85 From $80, Keeps Overweight Rating MT
11/11 Analyst recommendations: Coreweave, Duolingo, Lyft, Qualcomm, Tempus… Zonebourse
22/25/22 Analyst recommendations: 3M Company, Gartner, Halliburton, GM, Warner Bros Discovery… Zonebourse
22/25/22 Tempus AI Shares Lower After TD Cowen Downgrade MT
21/25/21 TD Cowen Downgrades Tempus AI to Hold From Buy, Adjusts Price Target to $88 From $72 MT
20/25/20 Canaccord Genuity Initiates Coverage on Tempus AI With Buy Rating, $110 Price Target MT
02/25/02 HC Wainwright Initiates Tempus AI at Buy With $90 Price Target MT
06/25/06 Healthcare firm Personalis' Q2 revenue misses estimates RE
21/25/21 BTIG Initiates Tempus AI at Buy With $60 Price Target MT
26/25/26 Wolfe Research Downgrades Tempus AI to Peer Perform From Outperform MT
25/25/25 Tempus AI Shares Fall After Downgrade from JPMorgan MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-2.03%
+41.72%
+26.36%
+10.61%
+10.61%
+16.9%
+37.16%
+42.61%
-17.48%
+30.19%
Average +19.66%
Weighted average by Cap. +21.87%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
76.61USD
Average target price
75.06USD
Spread / Average Target
-2.03%
High Price Target
100.00USD
Spread / Highest target
+30.53%
Low Price Target
35.00USD
Spread / Lowest Target
-54.31%

Analyst Consensus Detail

Analyst consensus - Tempus AI, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Tempus AI, Inc.
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Tempus AI, Inc.
  1. Stock Market
  2. Stocks
  3. TEM Stock
  4. Consensus Tempus AI, Inc.